Search Results - "Food and Drug Administration"

A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS‐CoV‐2(−)/(+) populations by Claire Steinbronn, Yashpal S. Chhonker, Jenell Stewart, Hannah Leingang, Kate B. Heller, Meighan L. Krows, Michael Paasche‐Orlow, Anna Bershteyn, Helen C. Stankiewicz Karita, Vaidehi Agrawal, Miriam Laufer, Raphael Landovitz, Mark Wener, Daryl J. Murry, Christine Johnston, Ruanne V. Barnabas, Samuel L. M. Arnold

Connect to this object online.

VNS in drug resistant epilepsy: preliminary report on a small group of patients by Iero Luisa, Cecconi Ilaria, Brunetto Daniela, Colonnelli Maria, Gentile Valentina, Franzoni Emilio, Moscano Filomena C, Cordelli Duccio M, Marchiani Valentina

Connect to this object online.

A real-world pharmacovigilance analysis for transthyretin inhibitors: findings from the FDA adverse event reporting database by Yuan Liu, Hao Li, Cheng Hu, Li Tan, Ping Yin, Zhihao Li, Shuangshan Zhou, Li Su

Connect to this object online.

In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease by Jason Vittitow, Ph.D, Robert Kissling, M.D, Heleen DeCory, Ph.D, Douglas Borchman, Ph.D

Connect to this object online.

Self-reported responsiveness to direct-to-consumer drug advertising and medication use: results of a national survey by Somes Grant W, Kukkamma Lisa, Dieringer Nicholas J, Shorr Ronald I

Connect to this object online.

Current treatment options for psoriatic arthritis: spotlight on abatacept by Ursini F, Russo E, De Giorgio R, De Sarro G, D'Angelo S

Connect to this object online.

Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel u... by Marla C. Dubinsky, Peter M. Irving, Remo Panaccione, April N. Naegeli, Alison Potts-Bleakman, Vipin Arora, Mingyang Shan, Simon Travis

Connect to this object online.

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook by Gopalakrishnan D, Koshkin VS, Ornstein MC, Papatsoris A, Grivas P

Connect to this object online.

A pilot analysis of morphometric assessment of itraconazole brands using dermoscopy and its relevance in the current scenario by Kabir Sardana, Ananta Khurana, Ajeet Singh, R K Gautam

Connect to this object online.

Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review by Kiran Kumar Rathinam, PharmD, Justin Jacob Abraham, PharmD, Thangavel Mahalingam Vijayakumar, PhD

Connect to this object online.

Mining Patients' Narratives in Social Media for Pharmacovigilance: Adverse Effects and Misuse of Methylphenidate by Xiaoyi Chen, Carole Faviez, Stéphane Schuck, Agnès Lillo-, Nathalie Texier, Badisse Dahamna, Badisse Dahamna, Charles Huot, Pierre Foulquié, Suzanne Pereira, Vincent Leroux, Pierre Karapetiantz, Armelle Guenegou-Arnoux, Sandrine Katsahian, Sandrine Katsahian, Cédric Bousquet, Anita Burgun, Anita Burgun

Connect to this object online.

Tracking the COVID-19 vaccines: The global landscape by Tushar Yadav, Swatantra Kumar, Gourav Mishra, Shailendra K. Saxena

Connect to this object online.

Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data by Quanfeng Zhao, Pan Ma, Peishu Fu, Jiayu Wang, Jiayu Wang, Kejing Wang, Kejing Wang, Lin Chen, Lin Chen, Yang Yang, Yang Yang

Connect to this object online.

Design and Construction of a Radiochemistry Laboratory and cGMP-Compliant Radiopharmacy Facility by Angela Asor, Abdullah Metebi, Kylie Smith, Kurt Last, Elaine Strauss, Jinda Fan

Connect to this object online.

Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy by Andrea C. Blackman, Aikaterini Anagnostou

Connect to this object online.

Regulatory guidelines do not accurately predict tolvaptan and metabolite interactions at BCRP, OATP1B1, and OAT3 transporters by Susan E. Shoaf, Patricia Bricmont, Jennifer Repella Gordon

Connect to this object online.

Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations by Rebwar Saeed M. Rashid, Selin Temurlu, Arwa Abourajab, Pelin Karsili, Meltem Dinleyici, Basma Al-Khateeb, Huriye Icil

Connect to this object online.

Perfil do uso de medicamentos durante a gravidez de puérperas internadas em um hospital do Brasil by DAYANI GALATO, ROSIANE DE BONA SCHRAIBER, SAMUEL DA SILVA LUNARDI, LORENNA RABÊLO MARQUES, EVELIN SOARES DE BRITO

Connect to this object online.

Pharmacist-led Smoking-Cessation Services in the United States - A Multijurisdictional Legal Analysis by Landon S. Bordner, Joseph Lavino

Connect to this object online.

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database by Shi-Nan Wu, Caihong Huang, Yu-Qian Wang, Xiang Li, Si-Qi Zhang, Xiao-Dong Chen, Dan-Yi Qin, Linfangzi Zhu, Jia-Yi Wen, Na-Chuan Luo, Jiaoyue Hu, Zuguo Liu

Connect to this object online.